KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Abbott Laboratories (ABT) FCF Payout Ratio (2016 - 2025)

Abbott Laboratories' FCF Payout Ratio history spans 17 years, with the latest figure at 0.39 for Q4 2025.

  • For Q4 2025, FCF Payout Ratio fell 12.05% year-over-year to 0.39; the TTM value through Dec 2025 reached 0.56, down 7.85%, while the annual FY2025 figure was 0.56, 7.85% down from the prior year.
  • FCF Payout Ratio for Q4 2025 was 0.39 at Abbott Laboratories, down from 0.45 in the prior quarter.
  • Across five years, FCF Payout Ratio topped out at 1.53 in Q1 2024 and bottomed at 0.33 in Q4 2021.
  • The 5-year median for FCF Payout Ratio is 0.46 (2021), against an average of 0.62.
  • The largest annual shift saw FCF Payout Ratio tumbled 80.13% in 2021 before it soared 213.66% in 2023.
  • A 5-year view of FCF Payout Ratio shows it stood at 0.33 in 2021, then skyrocketed by 47.43% to 0.48 in 2022, then fell by 18.9% to 0.39 in 2023, then grew by 14.66% to 0.45 in 2024, then decreased by 12.05% to 0.39 in 2025.
  • Per Business Quant, the three most recent readings for ABT's FCF Payout Ratio are 0.39 (Q4 2025), 0.45 (Q3 2025), and 0.67 (Q2 2025).